Polymer-assisted drug sequestration from plasma protein by a surfactant with curtailed denaturing capacity

Effect of salt addition on a triblock copolymer-zwitterionic surfactant assembly: insight from excited-state proton transfer

Copolymer-surfactant assemblies are frequently utilized across various fields, from medicine to nanotechnology. Understanding the organization of the mixed assemblies in a saline environment will further expand their application horizons, especially under physiological conditions. Excited-state proton transfer (ESPT) can provide insight into the hydration nature and organization of the non-toxic assembly of a triblock copolymer F127 (poly-(ethylene oxide)101 (PEO101)-poly(propylene oxide)56 (PPO56)-PEO101)) and a zwitterionic sulfobetaine surfactant N-dodecyl-N,N-dimethyl-3-ammoniopropane sulfonate (SB12). Here, we present a comprehensive investigation of the compactness and hydration nature of the F127-SB12 mixed assemblies at different salt concentrations using the ESPT of 8-hydroxy pyrene-1,3,6-trisulfonate (HPTS). In the absence of salts, gradual SB12 addition to a premicellar (0.4 mM) or a post-micellar (4 mM) F127 solution leads to an anomalous modulation of the protonated and deprotonated emission bands. The emission intensity ratio (protonated/deprotonated) first increases to a maximum at a particular SB12 concentration (6 mM and 35 mM for the premicellar and post-micellar F127 assemblies, respectively), and then the ratio decreases with a further increase in the surfactant concentration. Since the intensity ratio is an indicator of the retardation of the ESPT process, the mixed micellar configuration displaying a maximum intensity ratio represents the most compact and least hydrated state. Salt addition to this configuration lowers the intensity ratio, signifying an enhanced ESPT process. Dynamic light scattering (DLS) results indicate that the size of the mixed assembly remains almost unaltered with the addition of salts. Thus, salinity enhances the ESPT process inside the F127-SB12 mixed assemblies without significantly altering the hydrodynamic radius.

How do surfactants unfold and refold proteins?

Although the anionic surfactant sodium dodecyl sulfate, SDS, has been used for more than half a century as a versatile and efficient protein denaturant for protein separation and size estimation, there is still controversy about its mode of interaction with proteins. The term "rod-like" structures for the complexes that form between SDS and protein, originally introduced by Tanford, is not sufficiently descriptive and does not distinguish between the two current vying models, namely protein-decorated micelles a.k.a. the core-shell model (in which denatured protein covers the surface of micelles) versus beads-on-a-string model (where unfolded proteins are surrounded by surfactant micelles). Thanks to a combination of structural, kinetic and computational work particularly within the last 5-10 years, it is now possible to rule decisively in favor of the core-shell model. This is supported unambiguously by a combination of calorimetric and small-angle X-ray scattering (SAXS) techniques and confirmed by increasingly sophisticated molecular dynamics simulations. Depending on the SDS:protein ratio and the protein molecular mass, the formed structures can range from multiple partly unfolded protein molecules surrounding a single shared micelle to a single polypeptide chain decorating multiple micelles. We also have much new insight into how this species forms. It is preceded by the binding of small numbers of SDS molecules which subsequently grow by accretion. Time-resolved SAXS analysis reveals an asymmetric attack by SDS micelles followed by distribution of the increasingly unfolded protein around the micelle. The compactness of the protein chain continues to evolve at higher SDS concentrations according to single-molecule studies, though the protein remains completely denatured on the tertiary structural level. SDS denaturation can be reversed by addition of nonionic surfactants that absorb SDS forming mixed micelles, leaving the protein free to refold. Refolding can occur in parallel tracks if only a fraction of the protein is initially stripped of SDS. SDS unfolding is nearly always reversible unless carried out at low pH, where charge neutralization can lead to superclusters of protein-surfactant complexes. With the general mechanism of SDS denaturation now firmly established, it largely remains to explore how other ionic surfactants (including biosurfactants) may diverge from this path.

Exploring the Nucleobase-Specific Hydrophobic Interaction of Cryptolepine Hydrate with RNA and Its Subsequent Sequestration

The study of the interactions of drug molecules with genetic materials plays a key role underlying the development of new drugs for many life-threatening diseases in pharmaceutical industries. Understanding their fundamental base-specific and/or groove-binding interaction is crucial to target the genetic material with an external drug, which can pave the way to curing diseases related to the genetic material. Here, we studied the interaction of cryptolepine hydrate (CRYP) with RNA under physiological conditions knowing the antimalarial and anticancer activities of the drug. Our experiments explicitly demonstrate that CRYP interacts with the guanine- and adenine-rich region within the RNA duplex. The pivotal role of the hydrophobic interaction governing the interaction is substantiated by temperature-dependent isothermal titration calorimetry experiments and spectroscopic studies. Circular dichroism study underpins a principally intercalative mode of binding of CRYP with RNA. This interaction is found to be drastically affected in the presence of magnesium salt, which has a strong propensity to coordinate with RNA nucleobases, which can in turn modulate the interaction of the drug with RNA. The temperature-dependent calorimetric results substantiate the occurrence of entropy-enthalpy compensation, which enabled us to rule out the possibility of groove binding of the drug with RNA. Furthermore, our results also show the application of host-guest chemistry in sequestering the RNA-bound drug, which is crucial to the development of safer therapeutic applications.